JP2017526740A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526740A5 JP2017526740A5 JP2017527534A JP2017527534A JP2017526740A5 JP 2017526740 A5 JP2017526740 A5 JP 2017526740A5 JP 2017527534 A JP2017527534 A JP 2017527534A JP 2017527534 A JP2017527534 A JP 2017527534A JP 2017526740 A5 JP2017526740 A5 JP 2017526740A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- poly
- agonist
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/455,082 | 2014-08-08 | ||
| US14/455,082 US20140363496A1 (en) | 2011-01-07 | 2014-08-08 | Compositions and Methods for Inducing Nanoparticle-mediated Microvascular Embolization of Tumors |
| PCT/US2015/044017 WO2016022805A1 (en) | 2014-08-08 | 2015-08-06 | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526740A JP2017526740A (ja) | 2017-09-14 |
| JP2017526740A5 true JP2017526740A5 (enExample) | 2018-07-19 |
| JP6764864B2 JP6764864B2 (ja) | 2020-10-07 |
Family
ID=55264557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527534A Expired - Fee Related JP6764864B2 (ja) | 2014-08-08 | 2015-08-06 | 腫瘍のナノ粒子媒介微小血管塞栓形成を誘導するための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3177713B1 (enExample) |
| JP (1) | JP6764864B2 (enExample) |
| AU (1) | AU2015301014B2 (enExample) |
| CA (1) | CA2957552C (enExample) |
| ES (1) | ES2822557T3 (enExample) |
| WO (1) | WO2016022805A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016149562A2 (en) | 2015-03-17 | 2016-09-22 | Omniox, Inc. | Modulation of tumor immunity by protein-mediated 02 delivery |
| US10456452B2 (en) * | 2015-07-02 | 2019-10-29 | Poseida Therapeutics, Inc. | Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles |
| EP3449004B1 (en) | 2016-04-29 | 2021-02-24 | Poseida Therapeutics, Inc. | Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids |
| US20190119636A1 (en) | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
| CN110199015A (zh) | 2016-09-30 | 2019-09-03 | 波赛达治疗公司 | 修饰干细胞记忆t细胞、其制造方法与使用方法 |
| WO2018068022A1 (en) | 2016-10-06 | 2018-04-12 | Poseida Therapeutics, Inc. | Inducible caspases and methods for use |
| US10329543B2 (en) | 2017-10-23 | 2019-06-25 | Poseida Therapeutics, Inc. | Modified stem cell memory T cells, methods of making and methods of using same |
| JP2023531508A (ja) * | 2020-06-23 | 2023-07-24 | ヴィルテック バイオ，インク． | 出血性ショックを処置するための組成物および方法 |
| GB202108444D0 (en) * | 2021-06-14 | 2021-07-28 | Imperial College Innovations Ltd | Sub-micron particle |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612310A (en) | 1993-05-24 | 1997-03-18 | Duke University | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| GB9624540D0 (en) * | 1996-11-26 | 1997-01-15 | Nycomed Imaging As | Compositions |
| CA2348781A1 (en) * | 1998-11-12 | 2000-05-25 | Novolytics Inc. | Compositions and methods for producing vascular occlusion |
| JP2003531179A (ja) * | 2000-04-26 | 2003-10-21 | クイーンズ ユニバーシティ アット キングストン | 悪性細胞表現型に対し一酸化窒素模倣体を使用する処方および方法 |
| CA2459794C (en) * | 2001-09-12 | 2012-08-21 | Virexx Medical Corp. | Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| CN102026634B (zh) * | 2008-04-10 | 2014-01-22 | 弗吉尼亚州立邦联大学 | 诱导肿瘤缺氧以治疗癌症 |
| US9044454B2 (en) * | 2010-03-10 | 2015-06-02 | Northwestern University | Regulation of microvasculature occlusion |
| US8808748B2 (en) * | 2010-04-20 | 2014-08-19 | Vindico NanoBio Technology Inc. | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| WO2012094679A2 (en) * | 2011-01-07 | 2012-07-12 | Vindico NanoBio Technology Inc. | Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
-
2015
- 2015-08-06 AU AU2015301014A patent/AU2015301014B2/en not_active Ceased
- 2015-08-06 WO PCT/US2015/044017 patent/WO2016022805A1/en not_active Ceased
- 2015-08-06 ES ES15829211T patent/ES2822557T3/es active Active
- 2015-08-06 EP EP15829211.0A patent/EP3177713B1/en active Active
- 2015-08-06 CA CA2957552A patent/CA2957552C/en active Active
- 2015-08-06 JP JP2017527534A patent/JP6764864B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pushpalatha et al. | Nanocarrier mediated combination drug delivery for chemotherapy–A review | |
| Li et al. | Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer | |
| Narmani et al. | Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy | |
| Zhang et al. | The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment | |
| Zhu et al. | Applications of nanoparticles for anticancer drug delivery: a review | |
| CN108136023B (zh) | 血小板膜包覆的药物递送系统 | |
| Wang et al. | Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells | |
| Wang et al. | An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy | |
| CN108601746B (zh) | 用于运载物递送的具有脂质双层包衣的中孔二氧化硅纳米颗粒 | |
| Zhang et al. | Drug delivery systems for differential release in combination therapy | |
| Chavanpatil et al. | Surfactant–polymer nanoparticles overcome P-glycoprotein-mediated drug efflux | |
| CN109890420B (zh) | 用于递送治疗剂的血小板组合物和方法 | |
| Fatfat et al. | Micelles as potential drug delivery systems for colorectal cancer treatment | |
| Wan et al. | The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer | |
| Wang et al. | LFC131 peptide-conjugated polymeric nanoparticles for the effective delivery of docetaxel in CXCR4 overexpressed lung cancer cells | |
| Chen et al. | Synergistic antitumor efficacy of doxorubicin and gambogic acid-encapsulated albumin nanocomposites | |
| JP6764864B2 (ja) | 腫瘍のナノ粒子媒介微小血管塞栓形成を誘導するための組成物および方法 | |
| US20130022545A1 (en) | DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL | |
| Jeswani et al. | Advances in the delivery of cancer therapeutics: a comprehensive review | |
| Al-Amili et al. | Self-assembled micelles of amphiphilic PEGylated drugs for cancer treatment | |
| Srinivasan et al. | Nanobiomaterials in cancer therapy | |
| Jablonowski et al. | Manipulating multifaceted microbubble shell composition to target both TRAIL‐sensitive and resistant cells | |
| KR102348180B1 (ko) | 색전술용 마이크로캐리어 및 그 제조방법 | |
| Song et al. | Platelet membrane-coated poly (lactic-co-glycolic acid) nanoparticles as a targeting drug delivery system for multidrug-resistant breast cancer | |
| Hu et al. | Enhanced uptake and improved anti-tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer |